Name:

Influvac

Abbreviation:

TIV (Trivalent Inactivated Vaccine) or QIV (Quadrivalent Inactivated Vaccine) – depending on the vaccine type.

General Overview:

Influvac is an inactivated vaccine containing non-live viral components designed to stimulate the immune system.

The Influvac formulation is updated annually based on WHO recommendations and global epidemiological data to ensure alignment with circulating viral strains. It is available in both trivalent and quadrivalent versions, providing a broad range of immune protection.

The vaccine is typically produced in standardized doses and contains active ingredients without adjuvants, which reduces the frequency of side effects and improves tolerability across different age groups.

Influvac is stored at temperatures between 2°C and 8°C and is presented in pre-filled syringes for ease of use.

Vaccine efficacy depends significantly on individual patient characteristics and the match to circulating strains; however, Influvac’s safety and immunogenicity have been confirmed by numerous clinical studies, supporting its widespread use in both public health and clinical settings.